Update to IRAS, the Integrated Research Application System, will introduce a single, e-submission of IRAS Forms and associated documents.
We are writing to draw your attention to a change in the way that NHS costs are reviewed during grant applications. This is being driven primarily by new ways of handling NHS Excess Treatment Costs (ETCs) in England, but will also affect Scottish organisations applying to UK funders.
The Association of British Insurers (ABI) have confirmed to the Health Research Authority that participation in clinical trials does not affect eligibility criteria for travel insurance and have now withdrawn their guidance document “Clinical research trials and insurance”.
Accord Update/Training Events 2019
ACCORD: Bursaries for patient and public involvement in research
MHRA suspends use of certain Gadolinium contrast agents (GdCAs), and restricts uses of others.
A class 2 medicine recall – action within 48 hours – has now been issued by the MHRA for Magnevist (Bayer plc) and Omniscan Solution (GE Healthcare).
The General Data Protection Regulation (GDPR) was implemented on 25 May 2018, together with a new Data Protection Act.
Changes to IRAS from 18 October 2017
Changes to IRAS - Effective June 28th 2017